Receptors, Vascular Endothelial Growth Factor

"Receptors, Vascular Endothelial Growth Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular IG-LIKE DOMAINS which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.

Descriptor ID	D040262
MeSH Number(s)	D08.811.913.696.620.682.725.400.950 D12.776.543.750.630.750 D12.776.543.750.750.400.910
Concept/Terms	Receptors, Vascular Endothelial Growth Factor Receptors, Vascular Endothelial Growth Factor Receptor, Vascular Endothelial Cell Growth Factor Receptor, Vascular Permeability Factor VEGF Receptors Receptors, VEGF Vascular Endothelial Cell Growth Factor Receptor VPF Receptor Vascular Endothelial Growth Factor Receptor VEGF Receptor Vascular Permeability Factor Receptor Endothelial Growth Factor Receptor Endothelial Growth Factor Receptor Receptor, Endothelial Growth Factors

Below are MeSH descriptors whose meaning is more general than "Receptors, Vascular Endothelial Growth Factor".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Transferases [D08.811.913]
Phosphotransferases [D08.811.913.696]
Phosphotransferases (Alcohol Group Acceptor) [D08.811.913.696.620]
Protein Kinases [D08.811.913.696.620.682]
Protein-Tyrosine Kinases [D08.811.913.696.620.682.725]
Receptor Protein-Tyrosine Kinases [D08.811.913.696.620.682.725.400]
Receptors, Vascular Endothelial Growth Factor [D08.811.913.696.620.682.725.400.950]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptor Protein-Tyrosine Kinases [D12.776.543.750.630]
Receptors, Vascular Endothelial Growth Factor [D12.776.543.750.630.750]
Receptors, Peptide [D12.776.543.750.750]
Receptors, Growth Factor [D12.776.543.750.750.400]
Receptors, Vascular Endothelial Growth Factor [D12.776.543.750.750.400.910]

Below are MeSH descriptors whose meaning is related to "Receptors, Vascular Endothelial Growth Factor".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Vascular Endothelial Growth Factor".

Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor Receptor-3

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Vascular Endothelial Growth Factor" by people in this website by year, and whether "Receptors, Vascular Endothelial Growth Factor" was a major or minor topic of these publications.

Bar chart showing 10 publications over 9 distinct years, with a maximum of 2 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2002	0	1	1
2005	0	1	1
2008	0	1	1
2010	1	0	1
2011	0	1	1
2012	0	1	1
2013	1	1	2
2025	0	1	1

Below are the most recent publications written about "Receptors, Vascular Endothelial Growth Factor" by people in Profiles.

Ko MY, Talebi R, Yu F, Tseng VL, Coleman AL, Hosseini H. Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. Clin Ther. 2025 Aug; 47(8):559-565.

View in: PubMed
Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF. IL-32 promotes angiogenesis. J Immunol. 2014 Jan 15; 192(2):589-602.

View in: PubMed
Pearce WJ, Khorram O. Maturation and differentiation of the fetal vasculature. Clin Obstet Gynecol. 2013 Sep; 56(3):537-48.

View in: PubMed
Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, Williams JM, Khorram O, Pearce WJ. Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol Cell Physiol. 2012 Nov 15; 303(10):C1090-103.

View in: PubMed
Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4274-80.

View in: PubMed
VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW, Kittles RA, Kidd LC. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate. 2010 Mar 01; 70(4):341-52.

View in: PubMed
Le XF, Mao W, Lu C, Thornton A, Heymach JV, Sood AK, Bast RC. Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2. Cell Cycle. 2008 Dec; 7(23):3747-58.

View in: PubMed
Sridhar J, Akula N, Sivanesan D, Narasimhan M, Rathinavelu A, Pattabiraman N. Identification of novel angiogenesis inhibitors. Bioorg Med Chem Lett. 2005 Sep 15; 15(18):4125-9.

View in: PubMed
Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res. 2002 May 15; 62(10):2731-5.

View in: PubMed
Tallquist MD, Soriano P, Klinghoffer RA. Growth factor signaling pathways in vascular development. Oncogene. 1999 Dec 20; 18(55):7917-32.

View in: PubMed

People

Explore

Similar Concepts

Top Journals